Carlsmed Inc CARL
News
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical
Carlsmed, Inc. Announces Chief Operating Officer Appointment
Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance
Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026
